US › Healthcare

Absci Corp (ABSI)

US · Healthcare · Biotechnology

$8.48+6.94%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$215,000
Revenue YoY
-81.8%
Net profit
$-29.6M
Profit YoY
-12.3%
EPS
$-0.19
EPS estimate
$-0.20
Net margin
-13,767.0%

EPS came in at -0.19 against a street estimate of -0.20 — a beat of 5.0%.

Key statistics

Market cap
$1.32B
Forward P/E
0.0
P/B
7.67
Book value
$1.11
EPS (TTM)
$-0.82
52-week high
$12.05
52-week low
$2.24
50-day MA
$8.11
200-day MA
$4.64
Beta
2.33

Analyst view

Analysts rate Absci Corp a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $13.78.

Shareholding

Insiders
12.04%
Institutions
73.01%

Largest institutional holders

FundStake
FMR Inc13.31%
ARK Investment Management LLC8.10%
BlackRock Inc6.64%
Redmile Group, LLC4.87%
State Street Corp4.32%
Vanguard Capital Management, LLC3.48%
Advanced Micro Devices Inc3.37%
Geode Capital Management, LLC1.97%

Recent filings & reports

DocumentDate
Material agreement · Q2 20262026-06-24
Company announcement · Q2 20262026-06-24
Shareholder vote results · Q2 20262026-06-05
Quarterly report · Q1 20262026-05-07
Results announced · Q2 20262026-05-07
Proxy statement · Q2 20262026-04-22
Annual report FY20252026-03-24
Quarterly report · Q3 20252025-11-12

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Absci Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.